145 related articles for article (PubMed ID: 29386571)
21. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
22. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
23. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
[TBL] [Abstract][Full Text] [Related]
24. 5-HT7 receptor antagonism (SB-269970) attenuates bleomycin-induced pulmonary fibrosis in rats via downregulating oxidative burden and inflammatory cascades and ameliorating collagen deposition: Comparison to terguride.
Tawfik MK; Makary S
Eur J Pharmacol; 2017 Nov; 814():114-123. PubMed ID: 28821451
[TBL] [Abstract][Full Text] [Related]
25. [Effects of interleukin-17 on murine pulmonary fibroblast proliferation, transformation and collagen synthesis].
Dong Z; Kang Q; Lei W; Zhong H; Tai W; Wang D
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jan; 32(1):75-9. PubMed ID: 22366009
[TBL] [Abstract][Full Text] [Related]
26. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
27. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
28. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
[TBL] [Abstract][Full Text] [Related]
30. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
31. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
van den Brule S; Wallemme L; Uwambayinema F; Huaux F; Lison D
J Pharmacol Exp Ther; 2010 Nov; 335(2):472-9. PubMed ID: 20719937
[TBL] [Abstract][Full Text] [Related]
32. Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis.
Chen H; Qu J; Huang X; Kurundkar A; Zhu L; Yang N; Venado A; Ding Q; Liu G; Antony VB; Thannickal VJ; Zhou Y
Nat Commun; 2016 Aug; 7():12564. PubMed ID: 27535718
[TBL] [Abstract][Full Text] [Related]
33. Tectorigenin inhibits the in vitro proliferation and enhances miR-338* expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis.
Zhang H; Liu X; Chen S; Wu J; Ye X; Xu L; Chen H; Zhang D; Tan R; Wang Y
J Ethnopharmacol; 2010 Aug; 131(1):165-73. PubMed ID: 20600766
[TBL] [Abstract][Full Text] [Related]
34. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
35. [The expression of 5-HTR2B、E-cad、α-SMA in the pulmonary fibrosis in rats].
Tu RF; Zhang XF; He ZH
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Apr; 32(4):365-369. PubMed ID: 29931963
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
[TBL] [Abstract][Full Text] [Related]
37. Classical transient receptor potential 6 (TRPC6) channels support myofibroblast differentiation and development of experimental pulmonary fibrosis.
Hofmann K; Fiedler S; Vierkotten S; Weber J; Klee S; Jia J; Zwickenpflug W; Flockerzi V; Storch U; Yildirim AÖ; Gudermann T; Königshoff M; Dietrich A
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):560-568. PubMed ID: 27932059
[TBL] [Abstract][Full Text] [Related]
38. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
[TBL] [Abstract][Full Text] [Related]
39. [Up-regulation of miR-21 promotes cell proliferation and collagen synthesis in pulmonary fibroblasts].
Liu L; Qian H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):918-22. PubMed ID: 26146062
[TBL] [Abstract][Full Text] [Related]
40. Naftopidil reduced the proliferation of lung fibroblasts and bleomycin-induced lung fibrosis in mice.
Urushiyama H; Terasaki Y; Nagasaka S; Kokuho N; Endo Y; Terasaki M; Kunugi S; Makita K; Isago H; Hosoki K; Souma K; Ishii T; Matsuzaki H; Hiraishi Y; Mikami Y; Noguchi S; Tamiya H; Mitani A; Yamauchi Y; Shimizu A; Nagase T
J Cell Mol Med; 2019 May; 23(5):3563-3571. PubMed ID: 30873733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]